Apply
Overview
Alnylam was founded in 2002 on a revolutionary vision and bold mission to lead the translation of the Nobel Prize-winning science of RNA interference (RNAi) into a new class of innovative medicines with the potential to transform the lives of people suffering from serious illnesses. In 2018, Alnylam